Drugs / BCD-055
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02762812 | Jan 2016 → May 2017 | ankylosing spondylitis | Biocad | Completed | No outcome recorded |
| Phase 3 | NCT02762838 | Jan 2016 → Jul 2018 | rheumatoid arthritis | Biocad | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCD-055 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02762838 ↗ |